Literature DB >> 25006450

Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertension.

Levi Benson1, Evan L Brittain2, Meredith E Pugh3, Eric D Austin4, Kelly Fox4, Lisa Wheeler3, Ivan M Robbins3, Anna R Hemnes3.   

Abstract

Insulin resistance is highly prevalent in pulmonary arterial hypertension (PAH) patients. However, the long-term impact of diabetes mellitus (DM) on survival in PAH is unclear. Insulin resistance and DM are associated with left ventricular steatosis and dysfunction, but whether the right ventricle (RV) might be affected by DM in PAH is unknown. We hypothesized that PAH patients with DM would have worse survival than PAH patients without DM and that this would be due to impaired RV compensation. From a large registry of PAH patients at our institution, we analyzed the effect of DM on survival in patients with idiopathic or heritable PAH. Clinical and hemodynamic differences were compared between PAH patients with DM and those without DM. Twenty-nine patients with DM and 84 without DM were included. Gender, body mass index, PAH type and duration, and 6-minute walk distance were similar between groups. PAH patients with DM had significantly lower survival at 10 years than PAH patients without DM. Right atrial pressure, pulmonary arterial pressure, and cardiac output did not differ significantly between the two groups. However, right ventricular stroke work index (RVSWI) was lower in the PAH DM group than in the no-DM patients. Among PAH patients with DM, patients who died had a lower RVSWI than survivors. In conclusion, survival in PAH patients with DM was reduced compared to that of patients without DM; impaired RV compensation may underlie this finding. Further study is needed to understand this effect.

Entities:  

Keywords:  diabetes mellitus; pulmonary hypertension; right ventricle

Year:  2014        PMID: 25006450      PMCID: PMC4070784          DOI: 10.1086/675994

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  35 in total

1.  Cardiac output and related measurements and pressure values in the right heart and associated vessels, together with an analysis of the hemo-dynamic response to the inhalation of high oxygen mixtures in healthy subjects.

Authors:  B G BARRATT-BOYES; E H WOOD
Journal:  J Lab Clin Med       Date:  1958-01

Review 2.  Pulmonary arterial hypertension.

Authors:  Harrison W Farber; Joseph Loscalzo
Journal:  N Engl J Med       Date:  2004-10-14       Impact factor: 91.245

3.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

Review 4.  Updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; Ivan M Robbins; Maurice Beghetti; Richard N Channick; Marion Delcroix; Christopher P Denton; C Gregory Elliott; Sean P Gaine; Mark T Gladwin; Zhi-Cheng Jing; Michael J Krowka; David Langleben; Norifumi Nakanishi; Rogério Souza
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

5.  Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era.

Authors:  Marc Humbert; Olivier Sitbon; Ari Chaouat; Michèle Bertocchi; Gilbert Habib; Virginie Gressin; Azzedine Yaïci; Emmanuel Weitzenblum; Jean-François Cordier; François Chabot; Claire Dromer; Christophe Pison; Martine Reynaud-Gaubert; Alain Haloun; Marcel Laurent; Eric Hachulla; Vincent Cottin; Bruno Degano; Xavier Jaïs; David Montani; Rogério Souza; Gérald Simonneau
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

6.  Long-term treatment, tolerability, and survival with sub-cutaneous treprostinil for severe pulmonary hypertension.

Authors:  Roela Sadushi-Koliçi; Nika Skoro-Sajer; Daniel Zimmer; Diana Bonderman; Michael Schemper; Walter Klepetko; Jutta Glatz; Johannes Jakowitsch; Irene M Lang
Journal:  J Heart Lung Transplant       Date:  2012-04-04       Impact factor: 10.247

7.  Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model.

Authors:  K Mizushige; L Yao; T Noma; H Kiyomoto; Y Yu; N Hosomi; K Ohmori; H Matsuo
Journal:  Circulation       Date:  2000-02-29       Impact factor: 29.690

8.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

9.  Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension.

Authors:  Emma K Larkin; John H Newman; Eric D Austin; Anna R Hemnes; Lisa Wheeler; Ivan M Robbins; James D West; John A Phillips; Rizwan Hamid; James E Loyd
Journal:  Am J Respir Crit Care Med       Date:  2012-08-23       Impact factor: 21.405

Review 10.  Cellular and molecular basis of pulmonary arterial hypertension.

Authors:  Nicholas W Morrell; Serge Adnot; Stephen L Archer; Jocelyn Dupuis; Peter Lloyd Jones; Margaret R MacLean; Ivan F McMurtry; Kurt R Stenmark; Patricia A Thistlethwaite; Norbert Weissmann; Jason X-J Yuan; E Kenneth Weir
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

View more
  30 in total

1.  Diabetes Mellitus Associates with Increased Right Ventricular Afterload and Remodeling in Pulmonary Arterial Hypertension.

Authors:  Morgan E Whitaker; Vineet Nair; Shripad Sinari; Parinita A Dherange; Balaji Natarajan; Lindsey Trutter; Evan L Brittain; Anna R Hemnes; Eric D Austin; Kumar Patel; Stephen M Black; Joe G N Garcia; Jason X Yuan Md PhD; Rebecca R Vanderpool; Franz Rischard; Ayako Makino; Edward J Bedrick; Ankit A Desai
Journal:  Am J Med       Date:  2018-02-05       Impact factor: 4.965

Review 2.  Beyond the Lungs: Systemic Manifestations of Pulmonary Arterial Hypertension.

Authors:  Nils P Nickel; Ke Yuan; Peter Dorfmuller; Steeve Provencher; Yen-Chun Lai; Sebastien Bonnet; Eric D Austin; Carl D Koch; Alison Morris; Frédéric Perros; David Montani; Roham T Zamanian; Vinicio A de Jesus Perez
Journal:  Am J Respir Crit Care Med       Date:  2020-01-15       Impact factor: 21.405

3.  Mortality in US veterans with pulmonary hypertension: a retrospective analysis of survival by subtype and baseline factors.

Authors:  Aaron W Trammell; Amit J Shah; Lawrence S Phillips; C Michael Hart
Journal:  Pulm Circ       Date:  2019 Jan-Mar       Impact factor: 3.017

Review 4.  Pulmonary vascular dysfunction in metabolic syndrome.

Authors:  Conor Willson; Makiko Watanabe; Atsumi Tsuji-Hosokawa; Ayako Makino
Journal:  J Physiol       Date:  2018-09-12       Impact factor: 5.182

5.  Elevated 1-h post-load plasma glucose is associated with right ventricular morphofunctional parameters in hypertensive patients.

Authors:  Angela Sciacqua; Maria Perticone; Sofia Miceli; Angelina Pinto; Velia Cassano; Elena Succurro; Francesco Andreozzi; Marta Letizia Hribal; Giorgio Sesti; Francesco Perticone
Journal:  Endocrine       Date:  2019-02-21       Impact factor: 3.633

Review 6.  Fatty acid metabolism in pulmonary arterial hypertension: role in right ventricular dysfunction and hypertrophy.

Authors:  Megha Talati; Anna Hemnes
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

Review 7.  Metabolic Dysfunction in Pulmonary Arterial Hypertension.

Authors:  Tufik R Assad; Anna R Hemnes
Journal:  Curr Hypertens Rep       Date:  2015-03       Impact factor: 5.369

8.  SGLT inhibitors attenuate NO-dependent vascular relaxation in the pulmonary artery but not in the coronary artery.

Authors:  Ying Han; Young-Eun Cho; Ramon Ayon; Rui Guo; Katia D Youssef; Minglin Pan; Anzhi Dai; Jason X-J Yuan; Ayako Makino
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-11       Impact factor: 5.464

9.  Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.

Authors:  Longfei Wang; Gunner Halliday; Joshua R Huot; Taijyu Satoh; Jeffrey J Baust; Amanda Fisher; Todd Cook; Jian Hu; Theodore Avolio; Dmitry A Goncharov; Yang Bai; Rebecca R Vanderpool; Robert V Considine; Andrea Bonetto; Jiangning Tan; Timothy N Bachman; Andrea Sebastiani; Charles F McTiernan; Ana L Mora; Roberto F Machado; Elena A Goncharova; Mark T Gladwin; Yen-Chun Lai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-04-09       Impact factor: 8.311

10.  Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension.

Authors:  Tufik R Assad; Bradley A Maron; Ivan M Robbins; Meng Xu; Shi Huang; Frank E Harrell; Eric H Farber-Eger; Quinn S Wells; Gaurav Choudhary; Anna R Hemnes; Evan L Brittain
Journal:  JAMA Cardiol       Date:  2017-12-01       Impact factor: 14.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.